What to Expect When Starting Valproic Acid
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Introduction
Valproic acid (brand names Depakote, Depakene, Depacon) is a broad-spectrum anticonvulsant and mood stabilizer used for epilepsy (multiple seizure types), bipolar disorder (manic episodes), and migraine prevention [1]. It works by increasing brain levels of gamma-aminobutyric acid (GABA), blocking voltage-gated sodium channels, and modulating T-type calcium channels [2]. Valproic acid requires regular blood level monitoring to ensure therapeutic concentrations (50-100 mcg/mL for epilepsy, 85-125 mcg/mL for acute mania) and to detect potential hepatotoxicity or hematologic effects.
Week-by-week timeline
Starting the Initial Dose
For epilepsy, start at 10-15 mg/kg/day divided into 2-3 doses (or once daily with Depakote ER) [1]. For bipolar mania, loading strategies (20-30 mg/kg/day) may be used in acute settings. For migraine prevention, start at 250 mg twice daily. The most common early side effects are GI: nausea, vomiting, indigestion, and diarrhea (15-20%), which are significantly reduced by using divalproex sodium (Depakote) instead of valproic acid, and by taking it with food [1][2]. Drowsiness and dizziness are common initially.
Dose Adjustment and Blood Level Monitoring
The dose is adjusted based on clinical response and trough blood levels, which should be drawn just before the morning dose [1]. Baseline labs include CBC with differential, liver function tests (LFTs), and valproic acid level. Therapeutic blood levels are typically reached within 2-4 days of a stable dose. Weight gain begins for many patients and is one of the most common long-term concerns — average gain of 5-10 kg [2]. Tremor (dose-related, 25%), hair thinning (10-12%), and thrombocytopenia (platelet reduction) may emerge during titration.
Reaching Therapeutic Levels
By 4-8 weeks at a stable therapeutic dose, the full anticonvulsant or mood-stabilizing effect should be apparent [2]. For epilepsy, seizure frequency should be assessed relative to baseline. For bipolar disorder, mood stabilization typically develops over 1-4 weeks at therapeutic levels. For migraine prevention, allow 3 months at the target dose (500-1000 mg daily) before judging efficacy [1]. Side effects like tremor and GI issues often stabilize. Hair changes (thinning, altered texture) may become more apparent over weeks to months.
Long-Term Stabilization
Long-term monitoring includes periodic LFTs, CBC, valproic acid levels, and serum ammonia if symptoms of hyperammonemia develop (lethargy, confusion) [1]. Weight management strategies should be actively pursued, as valproate-associated weight gain plateaus at 6-12 months but rarely reverses spontaneously [2]. Women of childbearing potential require special counseling — valproic acid is classified as pregnancy category D/X with a 1-2% risk of neural tube defects and significant neurodevelopmental effects, making reliable contraception essential [1].
When to call your doctor
Contact your healthcare provider if you experience:
- Signs of liver toxicity: yellowing of skin or eyes, dark urine, persistent nausea/vomiting, severe abdominal pain, unusual fatigue — hepatotoxicity risk is highest in the first 6 months, especially in children under 2 [1]
- Signs of pancreatitis: severe abdominal pain (especially radiating to the back), persistent nausea/vomiting — can occur at any time during treatment [1]
- Unusual bleeding or bruising, petechiae (tiny red spots on skin), or prolonged bleeding from cuts — may indicate thrombocytopenia [1]
- Unexplained lethargy, confusion, or vomiting — may indicate hyperammonemic encephalopathy, which can occur even with normal liver function [1]
- Suicidal thoughts, worsening depression, or significant behavioral changes — all anticonvulsants carry an FDA warning for increased suicidal ideation [1]
- Pregnancy: contact your doctor immediately if you become pregnant or suspect pregnancy while taking valproic acid [1]
Tips for getting started
Take valproic acid/divalproex with food to reduce stomach upset [1]. Swallow Depakote tablets and Depakote ER whole — do not crush, chew, or break them. Never miss scheduled blood tests — monitoring blood levels, liver function, and blood counts is essential for safe use [1]. Discuss weight management proactively with your doctor, as weight gain is common and can be difficult to reverse. If you are a woman of childbearing potential, use highly effective contraception and discuss pregnancy planning well in advance — valproic acid requires careful management around pregnancy [2]. Do not stop abruptly — always taper under medical supervision to prevent breakthrough seizures or mood episodes.
Frequently asked questions
More about Valproic Acid
References
- [Regulatory] Depakote (divalproex sodium) FDA Prescribing Information. AbbVie. Revised 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018723s049lbl.pdf Accessed 2025-01-15.
- [Regulatory] Valproic Acid. StatPearls [Internet]. National Library of Medicine. Updated 2024. https://www.ncbi.nlm.nih.gov/books/NBK559112/ Accessed 2025-01-15.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: